Exploring the link between the germline and somatic genome in cancer

Por Geeleher, Paul, Huang, R. Stephanie
Publicado no Cancer Discov (2017)

Approaches to the discovery of pharmacogenomic markers in oncology: 2000–2010–2020

Por Huang, R Stephanie, Dolan, M Eileen
Publicado em 2010

Pharmacogenetics and Pharmacogenomics of Anticancer Agents

Por Huang, R. Stephanie, Ratain, Mark J.
Publicado em 2009

Translating pharmacogenomics discoveries into the clinic: an implementation framework

Por Huang, R Stephanie, Gamazon, Eric R
Publicado em 2013

Pharmacogenomics Discovery and Implementation in GWAS Era

Por Ni, Xiuqin, Zhang, Wei, Huang, R. Stephanie
Publicado em 2012

pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels

Por Geeleher, Paul, Cox, Nancy, Huang, R. Stephanie
Publicado em 2014

Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond

Por Delaney, Christopher, Frank, Samuel, Huang, R Stephanie
Publicado no Chin J Cancer (2015)

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

Por Rudin, Shoshana, Marable, Marcus, Huang, R. Stephanie
Publicado no Genomics Proteomics Bioinformatics (2017)

Integrating epigenomics into pharmacogenomic studies

Por Zhang, Wei, Huang, R Stephanie, Dolan, M Eileen
Publicado em 2008

Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent Toxicity

Por Zhang, Wei, Huang, R. Stephanie, Dolan, M. Eileen
Publicado em 2008

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

Por Geeleher, Paul, Cox, Nancy J, Huang, R Stephanie
Publicado em 2014

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer

Por Rose, Maimon C., Kostyanovskaya, Elina, Huang, R. Stephanie
Publicado no Genomics Proteomics Bioinformatics (2014)

Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models

Por Geeleher, Paul, Cox, Nancy J., Huang, R. Stephanie
Publicado no Genome Biol (2016)

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy

Por Weng, Liming, Zhang, Li, Peng, Yan, Huang, R Stephanie
Publicado em 2013

SCAN: A Systems Biology Approach to Pharmacogenomic Discovery

Por Gamazon, Eric R., Huang, R. Stephanie, Cox, Nancy J.
Publicado em 2013

Circulating MicroRNAs as Biomarkers for Inflammatory Diseases

Por Mi, Shuangli, Zhang, Jian, Zhang, Wei, Huang, R. Stephanie
Publicado em 2013

Gene set enrichment analyses revealed differences in gene expression patterns between males and females

Por Zhang, Wei, Huang, R. Stephanie, Duan, Shiwei, Dolan, M. Eileen
Publicado em 2009

The Impact of the Cancer Genome Atlas on Lung Cancer

Por Chang, Jeremy Tzu-Huai, Lee, Yee-Ming, Huang, R. Stephanie
Publicado no Transl Res (2015)

Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas

Por Chang, Jeremy T-H., Wang, Fan, Chapin, William, Huang, R. Stephanie
Publicado no PLoS One (2016)

High expression of miR-532-5p, a tumor suppressor, leads to better prognosis in ovarian cancer both in vivo and in vitro

Por Wang, Fan, Chang, Jeremy T-H., Kao, Chester Jingshiu, Huang, R. Stephanie
Publicado no Mol Cancer Ther (2016)